IL17A and asthma: While the authors do not suggest that DCQAs, alone or within a plant-based extract, are useful to relief rapidly occurring asthma attacks, a co-medication with other anti-inflammatory drugs might be beneficial due to DCQAs ability to decrease inflammatory mediators playing a role within asthma, such as IL-17, IL-6, or TNFα.